Growth response in Turner syndrome with recombinant human growth hormone therapy. 1995

C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
Department of Pediatrics, Siriraj Hospital, Vajira Hospital, Bangkok, Thailand.

Ten Turner syndrome girls whose mean age was 10.9 +/- 2.7 years were treated with recombinant human growth hormone (rhGH), dose 0.6 U/kg/week. Five of them had classical 45, XO karyotype. The mean height velocity increased from 2.8 +/- 1.3 cm/year before treatment to 6.1 +/- 2.06 cm/year after treatment for a period of 1.4 years. The response of treatment correlated well with pretreatment height velocity (<3 cm/year) but not with karyotype. However, the response has been decreasing and an increased dose after the first year of treatment is recommended.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D001846 Bone Development The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS. Bone Growth
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females

Related Publications

C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
January 2023, Pediatric endocrinology, diabetes, and metabolism,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
December 2008, Therapeutics and clinical risk management,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
February 2008, The Journal of clinical endocrinology and metabolism,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
May 2012, Pediatric endocrinology reviews : PER,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
January 2000, Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
April 2021, Journal of pediatric endocrinology & metabolism : JPEM,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
January 2003, The Cochrane database of systematic reviews,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
January 1998, Hormone research,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
January 1998, Hormone research,
C Tuchinda, and K Angsusingha, and L Punnakanta, and S Likitmaskul, and S Wacharasindhu, and K Tuanakitcharu, and P Pitukcheewanont
January 1990, Birth defects original article series,
Copied contents to your clipboard!